Tremfya and Enstilar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tremfya (guselkumab) and Enstilar (betamethasone dipropionate; calcipotriene). Common drug interactions include myocardial infarction among females and anal cancer among males.

The phase IV clinical study analyzes what interactions people have when they take Tremfya and Enstilar. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Tremfya?

Tremfya has active ingredients of guselkumab. eHealthMe is studying from 22,557 Tremfya users. Check the latest studies of Tremfya.

What is Enstilar?

Enstilar has active ingredients of betamethasone dipropionate; calcipotriene. eHealthMe is studying from 1,673 Enstilar users. Check the latest studies of Enstilar.

On Aug, 03, 2026

37 people who take Tremfya and Enstilar together, and have interactions are studied.

What are the common drug interactions of Tremfya and Enstilar, by gender? *:

female:

Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Urinary tract disorder
Breast cancer
Pyrexia (fever)
Drug ineffective
Chest pain
Diarrhoea
Vomiting
Abdominal discomfort
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)

male:

Anal cancer
Prostate cancer
Flatulence (flatus expelled through the anus)
Fungal infection
Pleural infection (infection of membrane of lungs)
Psoriasis (immune-mediated disease that affects the skin)
Toothache (tooth pain)
Urinary tract infection
Epstein-barr virus infection
B-cell lymphoma (blood cancer affecting b cells)

What are the common drug interactions of Tremfya and Enstilar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Diarrhoea

30-39:

Epstein-barr virus infection
Uterine polyp (a mass in the inner lining of the uterus)
Diarrhoea
Flatulence (flatus expelled through the anus)
Fungal infection
Toothache (tooth pain)

40-49:

B-cell lymphoma (blood cancer affecting b cells)
Menstruation irregular
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

50-59:

Drug ineffective
Abdominal discomfort
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Diarrhoea
Psoriasis (immune-mediated disease that affects the skin)
Shoulder operation

60+:

Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Urinary tract disorder
Pneumonia
Pericardial effusion (fluid around the heart)
Rash
Urticaria (rash of round, red welts on the skin that itch intensely)
Cellulitis (infection under the skin)
Inflammation
Urinary tract infection
Breast cancer

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 34 people, 91.89%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 8.11%
Hidradenitis (chronic disease of a type of sweat gland): 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Tremfya and Enstilar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously